MedTrace Logo

Product Surveillance Registry

NCT01524276 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000

Last updated 2026-05-20

No results posted yet for this study

Summary

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.

Conditions

  • Cardiac Rhythm Disorders
  • Urological Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Digestive Disorders
  • Intracranial Aneurysm
  • Mechanical Circulatory Support
  • Respiratory Therapy
  • Aortic, Peripheral Vascular and Venous Disorders
  • Minimally Invasive Surgical Procedures
  • Diagnostic Techniques and Procedures
  • Surgical Procedures, Operative
  • Renal Insufficiency
  • Neurovascular
  • Coronary Artery Disease
  • Ear, Nose and Throat Disorder

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2040-01-31
Completion
2040-01-31

Countries

  • United States
  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • Colombia
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • India
  • Ireland
  • Israel
  • Italy
  • Japan
  • Kuwait
  • Malaysia
  • Mexico
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Poland
  • Portugal
  • Puerto Rico
  • Saudi Arabia
  • Serbia
  • Slovakia
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01524276 on ClinicalTrials.gov